Jan Mattsson is CSO at ALBIREO PHARMA, INC. (ALBO). They have made 4 open-market trades across 1 company since 2018, most recently 2023-03-02.
CIK 0001687436
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALBO | 109,474 | $4.8M |
Shares reported on the most recent Form 4, priced at the 2023-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALBO | SELL · 10b5-1 | 2023-01-23 | 2023-01-23 | $43.80 | $9K | +1.8% | -0.6% | N/A |
| ALBO | SELL | 2023-01-19 | 2023-01-20 | $43.80 | $271K | +2.0% | -0.1% | N/A |
| ALBO | SELL · 10b5-1 | 2022-10-24 | 2022-10-25 | $19.58 | $4K | +8.2% | +10.4% | +119.7% |
| ALBO | SELL · 10b5-1 | 2022-07-22 | 2022-07-25 | $24.68 | $5K | +2.1% | -18.4% | -14.7% |
| ALBO | SELL · 10b5-1 | 2022-04-22 | 2022-04-25 | $32.92 | $7K | -7.1% | -39.7% | -30.2% |
| ALBO | SELL · 10b5-1 | 2022-01-24 | 2022-01-25 | $24.88 | $20K | +18.3% | +28.5% | +29.9% |
| ALBO | SELL | 2021-03-01 | 2021-03-05 | $36.66 | $1.7M | +6.2% | +2.2% | -10.4% |
| ALBO | SELL | 2020-09-08 | 2020-09-10 | $45.55 | $456K | -9.7% | -6.6% | -0.2% |
| ALBO | SELL | 2018-06-12 | 2018-06-14 | $32.26 | $1.6M | +13.7% | +3.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.